EP3634450A4 - Procédés et compositions pour modifier la dépendance à une protéine activant l'assemblage (app) de virus - Google Patents

Procédés et compositions pour modifier la dépendance à une protéine activant l'assemblage (app) de virus Download PDF

Info

Publication number
EP3634450A4
EP3634450A4 EP18799088.2A EP18799088A EP3634450A4 EP 3634450 A4 EP3634450 A4 EP 3634450A4 EP 18799088 A EP18799088 A EP 18799088A EP 3634450 A4 EP3634450 A4 EP 3634450A4
Authority
EP
European Patent Office
Prior art keywords
app
viruses
dependence
compositions
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP18799088.2A
Other languages
German (de)
English (en)
Other versions
EP3634450A1 (fr
Inventor
Luk H. VANDENBERGHE
Anna Claire MAURER
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Schepens Eye Research Institute Inc
Massachusetts Eye and Ear
Original Assignee
Massachusetts Eye and Ear Infirmary
Schepens Eye Research Institute Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Eye and Ear Infirmary, Schepens Eye Research Institute Inc filed Critical Massachusetts Eye and Ear Infirmary
Priority claimed from PCT/US2018/032166 external-priority patent/WO2018209154A1/fr
Publication of EP3634450A1 publication Critical patent/EP3634450A1/fr
Publication of EP3634450A4 publication Critical patent/EP3634450A4/fr
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14151—Methods of production or purification of viral material

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EP18799088.2A 2017-05-10 2018-05-10 Procédés et compositions pour modifier la dépendance à une protéine activant l'assemblage (app) de virus Pending EP3634450A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762504318P 2017-05-10 2017-05-10
PCT/US2018/032166 WO2018209154A1 (fr) 2017-05-10 2018-05-10 Procédés et compositions pour modifier la dépendance à une protéine activant l'assemblage (app) de virus

Publications (2)

Publication Number Publication Date
EP3634450A1 EP3634450A1 (fr) 2020-04-15
EP3634450A4 true EP3634450A4 (fr) 2021-03-31

Family

ID=69547516

Family Applications (1)

Application Number Title Priority Date Filing Date
EP18799088.2A Pending EP3634450A4 (fr) 2017-05-10 2018-05-10 Procédés et compositions pour modifier la dépendance à une protéine activant l'assemblage (app) de virus

Country Status (2)

Country Link
EP (1) EP3634450A4 (fr)
CN (1) CN110831611A (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3003391B1 (fr) * 2013-05-31 2021-09-22 The Regents of The University of California Variants de virus adéno-associés et leurs méthodes d'utilisation
NZ758021A (en) * 2013-10-11 2021-12-24 Massachusetts Eye & Ear Infirmary Methods of predicting ancestral virus sequences and uses thereof
GB201403684D0 (en) * 2014-03-03 2014-04-16 King S College London Vector

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] 23 June 2016 (2016-06-23), ZINN ERIC: "Adeno-associated virus capsid protein", XP055774598, Database accession no. AKU89600 *
ERIC ZINN ET AL: "In Silico Reconstruction of the Viral Evolutionary Lineage Yields a Potent Gene Therapy Vector", CELL REPORTS, vol. 12, no. 6, 1 August 2015 (2015-08-01), US, pages 1056 - 1068, XP055524241, ISSN: 2211-1247, DOI: 10.1016/j.celrep.2015.07.019 *
M. NAUMER ET AL: "Properties of the Adeno-Associated Virus Assembly-Activating Protein", JOURNAL OF VIROLOGY, vol. 86, no. 23, 1 December 2012 (2012-12-01), US, pages 13038 - 13048, XP055372879, ISSN: 0022-538X, DOI: 10.1128/JVI.01675-12 *
MAURER ANNA C. ET AL: "The Assembly-Activating Protein Promotes Stability and Interactions between AAV's Viral Proteins to Nucleate Capsid Assembly", CELL REPORTS, vol. 23, no. 6, 8 May 2018 (2018-05-08), US, pages 1817 - 1830, XP055774488, ISSN: 2211-1247, DOI: 10.1016/j.celrep.2018.04.026 *
See also references of WO2018209154A1 *

Also Published As

Publication number Publication date
EP3634450A1 (fr) 2020-04-15
CN110831611A (zh) 2020-02-21

Similar Documents

Publication Publication Date Title
EP3661966A4 (fr) Anticorps anti-cd39, compositions comprenant des anticorps anti-cd39 et méthodes d'utilisation d'anticorps anti-cd39
EP3638793A4 (fr) Compositions et procédés pour traiter des affections médiées par les récepteurs couplés aux protéines g
EP3270917A4 (fr) Composés et procédés de dégradation accrue de protéines ciblées
EP3302706A4 (fr) Compositions et procédés pour la dégradation de protéines mal pliées
EP3389672A4 (fr) Compositions et procédés de traitement de maladies hépatiques
EP3688012A4 (fr) Composés et procédés de modulation de la dégradation protéique
EP3576782A4 (fr) Compositions de produit de recombinaison-peptide et leurs méthodes d'utilisation
EP3185900A4 (fr) Formulations de protéines d'oeuf et leurs procédés de fabrication
EP3107999A4 (fr) Compositions destinées à l'inactivation de la réplication d'un virus et leurs procédés de fabrication et d'utilisation
EP3624773A4 (fr) Compositions ophtalmiques et leurs procédés d'utilisation
EP3265096A4 (fr) Compositions ophtalmiques et leurs procédés d'utilisation
EP3218370A4 (fr) Procédés et compositions pour l'inhibition de protéines extraterminales et à bromodomaine
EP3136875A4 (fr) Compositions de protéine de petite taille de particule et procédés de préparation
EP3589315A4 (fr) Compositions et procédés pour induire des anticorps anti-vih-1
EP3687524A4 (fr) Compositions et méthodes de traitement de troubles ophtalmiques
EP3423091A4 (fr) Compositions et procédés pour induire des anticorps du vih-1
EP3288379A4 (fr) Compositions de peptides et leurs méthodes d'utilisation
EP3324732A4 (fr) Procédés et compositions pour la régulation sélective de l'expression protéique
EP3565567A4 (fr) Compositions et méthodes de thérapie avec le virus de la dengue
EP3523321A4 (fr) Compositions et procédés d'expression et d'administration de protéines
EP3512341A4 (fr) Compositions à base de microalgues ayant un effet bénéfique pour les plantes et procédés d'application
EP3393460A4 (fr) Compositions et procédés de traitement de la miv et de maladies associées
EP3746058A4 (fr) Compositions et méthodes d'amélioration de la biodisponibilité de 5-hydroxytryptophane
EP3347477A4 (fr) Compositions et procédés de détection de protéine
EP3341006A4 (fr) Compositions et méthodes pour le traitement d'une lésion neurologique

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20191210

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40024595

Country of ref document: HK

A4 Supplementary search report drawn up and despatched

Effective date: 20210226

RIC1 Information provided on ipc code assigned before grant

Ipc: C07K 14/075 20060101ALI20210222BHEP

Ipc: C12N 15/86 20060101ALI20210222BHEP

Ipc: C07K 14/005 20060101ALI20210222BHEP

Ipc: A61K 35/761 20150101AFI20210222BHEP

Ipc: C12N 15/00 20060101ALI20210222BHEP

Ipc: C12N 15/09 20060101ALI20210222BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20220429